↓
 

Tag Archives: OMD

Dr. David Palma (Pt 2): Controversies and Open Questions in Radiation Oncology

Dr. Jack West & Dr. David Palma, expert radiation oncologist in London, Ontario, discuss challenges in delivering radiation in Canada as well debates in radiation oncology care ranging from proton beam radiation to SBRT for oligometastatic NSCLC. (31:07)

Dr. Jack West on New Data Combining Radiation with Immunotherapy in Advanced NSCLC: A Brief Critical Review

Dr. Jack West provides a brief summary of key findings & limitations of two new papers just out in JAMA Oncology (Theelen et al & Bauml et al.) that evaluate the potential benefit of preceding immunotherapy with radiation in patients with advanced NSCLC. (18:00)

Dr. Puneeth Iyengar (Pt 2): Open Questions and Controversies in Radiation Oncology Today

Host Dr. Jack West questions Dr. Puneeth Iyengar, radiation oncologist at UT-Southwestern, about proton beam radiation therapy, risks & benefits of cranial irradiation, & local ablative therapy for local consolidation therapy for oligometastatic disease. (31:39)

Dr. Greg Riely (Pt 2): Should local ablation therapy in oligometastatic or oligoprogressing cancer be incorporated into routine practice?

Dr. Greg Riely from MSKCC and Dr. Jack West review the changing role for plasma NGS and local ablation therapy (LAT) for oligometastic disease (OMD) or oligoprogressing advanced NSCLC in clinical practice. (28:11)

↑